Active — Not RecruitingNot Applicable

Salud en Mis Manos - Breast and Cervical Cancer Prevention and Early Detection - Expansion 2

United States8,000 participantsStarted 2020-02-20

Plain-language summary

The purpose of this study is to increase early detection and prevention of breast and cervical cancer through education and navigation and to increase breast and cervical cancer screening and Human Papillomavirus (HPV) vaccination in underserved Latinas.

Who can participate

Age range

18 Years – 74 Years

Sex

FEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Primarily residing in the Gulf Coast \& Lower Rio Grande Valley county areas (or other counties in Texas) * Women 40 years of age and older with no mammogram in the past 2 years * Women 21-65 years, with no Pap test in the past 3 years * Women aged 18-26 years, who have not initiated or completed the HPV vaccine series, and through age 45 years if Advisory Committee on Immunization Practices (ACIP) recommends the FDA-approved age expansion for HPV vaccination for older individuals. Exclusion Criteria: * Current pregnancy * Have a current or prior cancer diagnosis

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Number of women 40 and older who complete mammogram screening

Timeframe: Between baseline and end of study (about 9 months)

Number of women 21-65 years who complete Pap test screening

Timeframe: Between baseline and end of study (about 9 months)

Number of women 18-26 years who initiate (complete first dose) of the HPV vaccine

Timeframe: Between baseline and end of study (about 9 months)

Trial details

NCT IDNCT06082882

SponsorThe University of Texas Health Science Center, Houston

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-08-31

View on ClinicalTrials.gov More Breast Cancer trials

Who can participate

Age range

18 Years – 74 Years

Sex

FEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

Number of women 40 and older who complete mammogram screening

Timeframe: Between baseline and end of study (about 9 months)

Number of women 21-65 years who complete Pap test screening

Timeframe: Between baseline and end of study (about 9 months)

Number of women 18-26 years who initiate (complete first dose) of the HPV vaccine

Timeframe: Between baseline and end of study (about 9 months)